| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/21/2006 | US7015006 Obtaining a sample of red blood cells separated from whole blood, detecting type IV cytosolic phospholipase A2 (cPLA2) protein or such protein immunologically homologous in or on the red blood cells with an antibody to type 4 cPLA2 protein |
| 03/21/2006 | US7015002 Method of detecting biological molecules, and labeling dye and labeling kit used for the same |
| 03/21/2006 | US7015001 Comprises nucleotide sequences coding spinosyn-A biosynthetic enzyme for preparing pesticides; biological pest control agents |
| 03/21/2006 | US7015000 Probes labeled with energy transfer coupled dyes |
| 03/21/2006 | US7014999 Topographic genotyping |
| 03/21/2006 | US7014997 Chromosome structural abnormality localization with single copy probes |
| 03/21/2006 | US7014996 Diagnosing the presence of gynecologic cancers by analyzing for changes in levels of ESBPIII in cells, tissues or bodily fluids compared with levels of ESBPIII in preferably the same cells, tissues, or bodily fluid type of a normal human control |
| 03/21/2006 | US7014994 high abundance wild-type sequence is selectively removed using high fidelity polymerase chain reaction analog conversion, facilitated by optimal buffer conditions, to create a restriction endonuclease site in the high abundance wild-type gene, but not in the low abundance mutant gene |
| 03/21/2006 | US7014993 DNA encoding a Tumor Antigen Derived Gene-14 (TADG-14) protein |
| 03/21/2006 | US7014992 Conductive oligomers attached to electrodes and nucleoside analogs |
| 03/21/2006 | US7014854 Method for retarding or precluding Alzheimer's dementia |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/21/2006 | CA2281769C Method for identifying cholesterol in the skin tissue |
| 03/21/2006 | CA2154080C Novel anticoagulant cofactor activity |
| 03/16/2006 | WO2006029256A2 Compositions, methods, and systems for determining bovine parentage and identity |
| 03/16/2006 | WO2006029248A2 Hollow fiber technique for in vivo study of cell populations |
| 03/16/2006 | WO2006029184A2 Genes useful for diagnosing and monitoring inflammation related disorders |
| 03/16/2006 | WO2006029172A2 Methods to identify and quantify oligosaccharide modifications of glycoproteins |
| 03/16/2006 | WO2006029029A2 Compositions for detection of latent hiv reactivation and methods of using the same |
| 03/16/2006 | WO2006029014A2 rRNA OLIGONUCLEOTIDE PROBES FOR SPECIFIC DETECTION OF MYCOBACTERIA AND METHODS OF USE THEREOF |
| 03/16/2006 | WO2006028999A2 Assessment of ctla-4 polymorphisms in ctla-4 blockade therapy |
| 03/16/2006 | WO2006028987A2 Nucleic acid amplification with integrated multiplex detection |
| 03/16/2006 | WO2006028867A2 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 03/16/2006 | WO2006028655A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 03/16/2006 | WO2006028634A2 Site specific pegylation of broadly-neutralizing antibodies against hepatitis c virus and their use in the treatment of chronic hcv infections |
| 03/16/2006 | WO2006028616A1 Compositions and methods for using a solid support to purify dna |
| 03/16/2006 | WO2006028591A2 Novel recombinant t4 phage particles and uses thereof |
| 03/16/2006 | WO2006028586A2 Biomarkers and therapeutic targets for cognitive decline |
| 03/16/2006 | WO2006028585A2 Optical fiber bundle for detecting binding of chemical species |
| 03/16/2006 | WO2006028565A2 Novel methods for high-throughput genome-wide location analysis |
| 03/16/2006 | WO2006028517A2 Comparative genomic resequencing |
| 03/16/2006 | WO2006028508A2 Methods and apparatus for characterizing polynucleotides |
| 03/16/2006 | WO2006028496A2 Lesion repair polymerase compositions |
| 03/16/2006 | WO2006028492A2 hC1Q/TNF7 AND USES THEREOF |
| 03/16/2006 | WO2006028310A1 In-gel tagging and in-gel digestion for phosphoproteins analysis and phosphorylation site identification |
| 03/16/2006 | WO2006028152A1 Method of analyzing gene copy and apparatus therefor |
| 03/16/2006 | WO2006027913A1 Feature pattern recognizing system, method, and program |
| 03/16/2006 | WO2006027698A1 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 03/16/2006 | WO2006027696A2 Process to obtain a molecular marker to determine the sex type in borojo plants |
| 03/16/2006 | WO2006027606A2 Screening method |
| 03/16/2006 | WO2006027532A1 Device for transferring elements contained in a liquid |
| 03/16/2006 | WO2006027496A1 Plasmid comprising an encoding gene for a glutamate deshydrogenas of lactococcus lactis |
| 03/16/2006 | WO2006027471A1 Systematic directed mutagenesis method |
| 03/16/2006 | WO2006027468A2 Hla-dp4 restricted t cd4+ du vih epitopes and the use thereof |
| 03/16/2006 | WO2006027463A2 Biochip for determining sensitivity to an anticancer drug |
| 03/16/2006 | WO2006027260A1 Use of a gene modification in the gene of the human cdca3 protein in medical diagnosis and therapy |
| 03/16/2006 | WO2006027192A2 Biomarkers for acute graft rejection |
| 03/16/2006 | WO2006027182A1 Methods and its kits based on ugt1a7 promoter polymorphism |
| 03/16/2006 | WO2006027147A2 Diagnostics and therapeutics for diseases associated with adrenomedullin receptor (amdr) |
| 03/16/2006 | WO2006027128A1 Association of protein polymorphisms with coronary heart disease |
| 03/16/2006 | WO2006026994A1 Crystal structure of house dust mite allergen der p 1 |
| 03/16/2006 | WO2006026946A1 Device and method for the detection of charged macromolecules |
| 03/16/2006 | WO2006014639A3 Sequencing of modified nucleic acid molecules |
| 03/16/2006 | WO2006005055A3 Methods reaction mixtures and kits for ligating polynucleotides |
| 03/16/2006 | WO2005123961A9 Approaches to identifying mutations associated with hereditary nonpolyposis colorectal cancer |
| 03/16/2006 | WO2005123949A3 Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof |
| 03/16/2006 | WO2005118881A3 Carrier tests for polycystic kidney disease in the cat |
| 03/16/2006 | WO2005118874A9 Enhancing protein expression |
| 03/16/2006 | WO2005118852A3 A marker for prenatal diagnosis and monitoring |
| 03/16/2006 | WO2005118813A3 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein |
| 03/16/2006 | WO2005116645A3 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 03/16/2006 | WO2005111625A3 Method to predict prostate cancer |
| 03/16/2006 | WO2005111605A3 Biomarkers for the prediction and treatment of drug-induced diarrhoea |
| 03/16/2006 | WO2005108998A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor beta-3 adreno (adrb3) |
| 03/16/2006 | WO2005106488A3 Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) |
| 03/16/2006 | WO2005101011A3 Diagnostics and therapeutics for diseases associated with lxr-alpha (lxra) |
| 03/16/2006 | WO2005095984A3 Diagnostics and therapeutics for diseases associated with g protein-coupled alpha 2a-adrenoceptor (adra2a) |
| 03/16/2006 | WO2005091992A3 Oligonucleotide compositions targeting egr-1 forcancer treatment |
| 03/16/2006 | WO2005090994A3 Diagnostics and therapeutics for diseases associated with protein kinase, cgmp-dependent, type i (prkg1) |
| 03/16/2006 | WO2005083440A3 Identification of cancer protein biomarkers using proteomic techniques |
| 03/16/2006 | WO2005077007A3 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 03/16/2006 | WO2005063817A3 Methods for identifying functional antibodies |
| 03/16/2006 | WO2005061736A3 Sleep genes in drosophila and their use for the screening, diagnosis and therapy of sleep disorders |
| 03/16/2006 | WO2005054270A3 Identification and design of sirna molecules |
| 03/16/2006 | WO2005038029A3 Luciferase biosensor |
| 03/16/2006 | WO2005026691A3 Detection of 13q14 chromosomal alterations |
| 03/16/2006 | WO2005019795A3 Electrochemical sensors including electrode systems with increased oxygen generation |
| 03/16/2006 | WO2005012548A3 Self-hybridizing multiple target nucleic acid probes and methods of use |
| 03/16/2006 | WO2005007119A3 Assays for protease enzyme activity |
| 03/16/2006 | WO2004092342A3 Lateral flow system for nucleic acid detection |
| 03/16/2006 | WO2004081228A3 Real time gene expression profiling |
| 03/16/2006 | WO2004069850A3 Switchable nucleic acids for diagnostics, screening and molecular electronics |
| 03/16/2006 | WO2004000220A3 Methods for purifying viral particles for gene therapy |
| 03/16/2006 | WO2003076333A3 Crystalline structure of human mapkap kinase-2 |
| 03/16/2006 | WO2003070082A3 Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer |
| 03/16/2006 | US20060059590 Cotton event mon 88913 and compositions and methods for detection thereof |
| 03/16/2006 | US20060059580 use biomarkers to identify, select and/or construct disease resistant plants or identify and counter-select disease-susceptible plants |
| 03/16/2006 | US20060058970 Analytical method for reducing quantitative analysis systematic error of real-time fluorescence thermal cycler and the applications of the same |
| 03/16/2006 | US20060058967 Method of designing probe set, microarray having substrate on which probe designed by the method is immobilized, and computer readable medium on which program for executing the method is recorded |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058520 Detecting activity of a Silent information regulator 2 by combining the composition with adenosine 5'-diphosphate and an acetylated Sir2 peptide substrate to deacetylate the peptide, and identifying 2'/3'-O-acetyl-ADP-ribose in the mixture to determine the presence of Sir2 activity |
| 03/16/2006 | US20060058518 Incubating nucleic acid in solution for deamination; desulfonation; conversion of cytosine base to uracil |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058507 Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058227 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis |
| 03/16/2006 | US20060058225 Used of inhibitors of phospholipase a2 for the treatment, prevention or diagnosis of neural inflammatory or demyelinating disease |
| 03/16/2006 | US20060058217 Compositions and methods for treatment of ovarian cancer |
| 03/16/2006 | US20060058190 Malate dehydrogenase as a target for herbicides |